<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors present their results regarding the use of a buffered solution of <z:chebi fb="3" ids="17754">glycerol</z:chebi> 30%-<z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="22651">ascorbate</z:chebi> 20% (GLIAS) for the treatment of <z:hpo ids='HP_0002181'>brain oedema</z:hpo> and intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>GLIAS was perfused intravenously in 80 patients with several types of <z:hpo ids='HP_0002181'>brain oedema</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In every patients serum and urinary osmolarity, <z:mp ids='MP_0001762'>diuresis</z:mp>, main blood and urine parameters, and ICP were monitored </plain></SENT>
<SENT sid="3" pm="."><plain>Following GLIAS infusion an increase in plasma osmolarity was observed, changing the average basal value plus 13.4% after 15 min., 10.5% after 30' </plain></SENT>
<SENT sid="4" pm="."><plain>At the same time there was a reduction of ICP and improvement in cerebral compliance </plain></SENT>
<SENT sid="5" pm="."><plain>In each case there was a decrease in intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0002181'>brain oedema</z:hpo> without significant collateral effects </plain></SENT>
</text></document>